Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erythematous Rosacea”

5 trials

Showing 5 of 5 results

Not applicableStudy completedNCT06908915
What this trial is testing

Long Pulse 1064 nm Nd:YAG Laser in the Treatment of Erythematotelangiectatic Rosacea and Other Erythematous Telangiectatic Facial Conditions

Who this might be right for
Rosacea, Erythematotelangiectatic
Hawler Medical University 30
Not applicableLooking for participantsNCT07106957
What this trial is testing

Efficacy and Safety Evaluation of CICAPLAST BAUME B5+ on Rosacea Accompanied by Sensitive Skin

Who this might be right for
Erythematous Telangiectatic Rosacea
Beijing Sino-German Union Cosmetic Institute Co., Ltd. 72
Testing effectiveness (Phase 2)Study completedNCT00697541
What this trial is testing

Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%

Who this might be right for
Erythematous Rosacea
Galderma R&D 20
Not applicableLooking for participantsNCT07343635
What this trial is testing

The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea

Who this might be right for
Erythematotelangiectatic Rosacea
The Fourth Affiliated Hospital of Zhejiang University School of Medicine 186
Testing effectiveness (Phase 2)Study completedNCT01186068
What this trial is testing

Dose Response Study of Patients With Erythematous Rosacea

Who this might be right for
Erythematous (Type One) Rosacea
Vicept Therapeutics, Inc. 175

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation